T
TRYP Therapeutics Inc
CNSX:TRYP
TRYP Therapeutics Inc
CNSX:TRYP
Price:
0.06
CAD
Market Closed
Market Cap:
CA$5.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
T
|
TRYP Therapeutics Inc
CNSX:TRYP
|
CA |
|
Universal Health Services Inc
NYSE:UHS
|
US |
|
Elan Microelectronics Corp
TWSE:2458
|
TW |
|
Safestore Holdings PLC
LSE:SAFE
|
UK |
|
E
|
Ecomembrane SpA
MIL:ECMB
|
IT |
|
L
|
Luxchem Corporation Bhd
KLSE:LUXCHEM
|
MY |
|
Fudo Tetra Corp
TSE:1813
|
JP |
|
Better Life Commercial Chain Share Co Ltd
SZSE:002251
|
CN |
Income Statement
Earnings Waterfall
TRYP Therapeutics Inc
TRYP Therapeutics Inc
Income Statement
TRYP Therapeutics Inc
TRYP Therapeutics Inc
Currency: CAD
| Feb-2021 | May-2021 | Aug-2021 | Nov-2021 | Feb-2022 | May-2022 | Aug-2022 | Nov-2022 | Feb-2023 | May-2023 | Aug-2023 | Nov-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||
| Operating Expenses |
(2)
|
(5)
|
(7)
|
(10)
|
(10)
|
(8)
|
(7)
|
(6)
|
(6)
|
(6)
|
(5)
|
(4)
|
|
| Selling, General & Administrative |
(2)
|
(5)
|
(6)
|
(8)
|
(8)
|
(6)
|
(4)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
|
| Research & Development |
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
(4)
|
(4)
|
(2)
|
(2)
|
|
| Operating Income |
(2)
N/A
|
(5)
-108%
|
(7)
-47%
|
(10)
-34%
|
(10)
-1%
|
(8)
+19%
|
(7)
+8%
|
(6)
+19%
|
(6)
+5%
|
(6)
-1%
|
(5)
+18%
|
(4)
+14%
|
|
| Pre-Tax Income | |||||||||||||
| Interest Income Expense |
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Non-Reccuring Items |
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
|
| Pre-Tax Income |
(3)
N/A
|
(6)
-77%
|
(8)
-40%
|
(11)
-30%
|
(10)
+8%
|
(8)
+18%
|
(7)
+7%
|
(6)
+18%
|
(6)
+4%
|
(6)
-1%
|
(5)
+10%
|
(5)
+9%
|
|
| Net Income | |||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(3)
|
(6)
|
(8)
|
(11)
|
(10)
|
(8)
|
(7)
|
(6)
|
(6)
|
(6)
|
(5)
|
(5)
|
|
| Net Income (Common) |
(3)
N/A
|
(6)
-77%
|
(8)
-40%
|
(11)
-30%
|
(10)
+8%
|
(8)
+18%
|
(7)
+7%
|
(6)
+18%
|
(6)
+4%
|
(6)
+2%
|
(5)
+8%
|
(5)
+9%
|
|
| EPS (Diluted) |
-0.07
N/A
|
-0.08
-14%
|
-0.14
-75%
|
-0.18
-29%
|
-0.16
+11%
|
-0.09
+44%
|
-0.1
-11%
|
-0.08
+20%
|
-0.06
+25%
|
-0.06
N/A
|
-0.05
+17%
|
-0.05
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
